Sodium Nitroprusside Injection, Solution, Concentrate
NDC Package 70069-261-01
Package Information
Sodium Nitroprusside injection is sodium nitroprusside is indicated for the immediate reduction of blood pressure of adult and pediatric patients in hypertensive crises. This formulation utilizes a injection, solution, concentrate delivery system. Marketed by Somerset Therapeutics, Llc, this product is identified by NDC 70069-261 and is authorized under FDA application ANDA210882.
Identification & Billing
- RxCUI: 240793 - sodium nitroprusside 50 MG in 2 ML Injection
- RxCUI: 240793 - 2 ML sodium nitroprusside 25 MG/ML Injection
- RxCUI: 240793 - sodium nitroprusside 25 MG/ML per 2 ML Injection
- RxCUI: 240793 - sodium nitroprusside 50 MG per 2 ML Injection
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70069 - Somerset Therapeutics, Llc
- 70069-261 - Sodium Nitroprusside
- 70069-261-01 - 1 VIAL in 1 CARTON / 2 mL in 1 VIAL
- 70069-261 - Sodium Nitroprusside
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70069-261-01 identifies a specific commercial package of 1 vial in 1 carton / 2 ml in 1 vial of Sodium Nitroprusside, a human prescription drug labeled by Somerset Therapeutics, Llc. This injection, solution, concentrate is formulated for intravenous use and contains sodium nitroprusside as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Somerset Therapeutics, Llc on August 17, 2018. The current certification is valid through December 31, 2026.
How is this Somerset Therapeutics, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70069026101. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.